PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy

Qian Li1, Jingjing Han1, Yonglin Yang2

  • 1Department of Anesthesiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Frontiers in Immunology
|January 5, 2023
PubMed

Related Concept Videos